How to Respond to a Notice of Allegation in Canada Patent Form: Section 6 Actions, 45‑day Deadline, PM(NOC) Pleading Traps

Last updated: 10 July 2026

Knowing how to respond to a notice of allegation in Canada patent form is one of the most time‑critical tasks a brand‑side pharmaceutical or biotech legal team will face. Under the Patented Medicines (Notice of Compliance) Regulations (SOR/93‑133), a first person (typically the innovator patent owner) has only 45 days from service of a Notice of Allegation (NOA) to commence a section 6 action in the Federal Court of Canada, or lose the automatic regulatory stay that prevents Health Canada from issuing a notice of compliance to the generic applicant.

This guide delivers the step‑by‑step tactical playbook that existing resources lack: a first‑48‑hours triage checklist, the key forms and database checks to complete within seven days, a decision matrix for commencing the section 6 action, an essential‑documents template for drafting the statement of claim, and the seven most common pleading traps that can cost a patent holder the stay.

TL;DR, What to Do When You Receive a Notice of Allegation (Quick Action Plan)

When an NOA lands on your desk, the clock starts immediately: you have 45 calendar days from date of service to commence a section 6 action in Federal Court or the statutory stay will not apply. Below is the ten‑point action plan for the first 48 hours.

1. Log the exact date and method of service, this anchors every downstream deadline.
2. Make certified copies of the NOA and all accompanying materials (the detailed statement).
3. Confirm which patent(s) the NOA addresses and cross‑reference them against the Health Canada Patent Register.
4. Verify the Drug Identification Number (DIN) and submission type of the second person’s drug product in the notice of compliance database.
5. Pull and archive a dated printout of every relevant Patent Register entry.
6. Check whether a Certificate of Supplementary Protection (CSP) exists for any listed patent.
7. Retrieve your own Form IV filings and Submission Certification Forms to confirm correct listing dates.
8. Brief external litigation counsel, share the NOA, Patent Register printouts and a chronology of key regulatory dates.
9. Issue a litigation hold and document‑preservation notice to all relevant custodians.
10. Commence preliminary claim construction analysis and infringement assessment against the NOA allegations.

Every item above feeds directly into the strategic decision covered in Section 4: whether to commence a section 6 action or pursue alternative resolution within the 45‑day window, as required under the PM(NOC) Regulations.

Background: PM(NOC) Regulations, Patent Register and the Statutory Trigger

The Patented Medicines (Notice of Compliance) Regulations create a linkage regime that ties drug regulatory approval to patent rights. Their purpose is to balance early market entry by generic and biosimilar manufacturers against the patent rights of innovators. When a second person files an abbreviated new drug submission (ANDS) or a supplement referencing an innovator’s product, and the innovator’s patent is listed on the Health Canada Patent Register, the second person must either accept the patent or serve a Notice of Allegation on the first person asserting that the patent is invalid, not infringed, or otherwise inapplicable.

Key Statutory Terminology

Section 5 of the PM(NOC) Regulations sets out the requirement for the second person to serve the NOA together with a detailed statement of the legal and factual basis for each allegation. This detailed statement is the roadmap the first person uses when evaluating the strength of the allegations and preparing a response.

How the Patent Register Works

Health Canada maintains the Patent Register as a publicly searchable database listing patents that relate to approved drug products. A first person submits patent information to Health Canada using the prescribed form (commonly referenced as Form IV), and Health Canada adds the patent to the register if it meets eligibility criteria, for example, the patent must contain a claim for the medicinal ingredient, a formulation, or a dosage form, or a claim for the use of the medicinal ingredient. The register is searchable through the Health Canada Patent Register page. Only patents that appear on the register at the time the second person files its submission trigger the NOA requirement.

This makes confirming register status one of the first critical verification steps after receiving an NOA.

Verify Receipt and Date Evidence (First 7 Days), Forms and Database Checks

Accurate verification during the first week after receiving the NOA is essential, errors in date evidence or register status can undermine the section 6 action later. Industry observers find that the most common early mistakes are failing to confirm the precise date of service and neglecting to check whether all relevant patents were actually on the register at the correct statutory moment.

How to Read a Patent Register Entry

Access the Patent Register search tool and enter the DIN or brand name. Each entry displays several fields that are tactically important:

Health Canada Forms to Capture (Form IV and Submission Certification)

Retrieve your own Form IV filing, the form used to submit patent information to Health Canada for listing on the Patent Register. Confirm the submission date, the patent claims category declared, and whether Health Canada acknowledged listing. Also obtain a copy of the Submission Certification Form, which the second person files with its ANDS. Where possible, request a copy of the second person’s Form V (the form used to allege non‑infringement or invalidity, or to accept the patent). These documents establish the chronological foundation for the section 6 action and will be required as exhibits. Take timestamped screenshots of all online database entries on the date of retrieval, courts expect contemporaneous evidence of register status.

45‑Day Decision: Commence a Section 6 Action or Not, Legal Threshold and Tactical Considerations

The 45‑day deadline is the pivotal strategic window. If the first person commences proceedings within 45 days of being served with the NOA, Health Canada is prohibited from issuing a notice of compliance to the second person until the earlier of the court’s determination or 24 months from the date the proceedings were commenced, subject to any court orders. Failure to commence within 45 days means no automatic stay, the generic may receive its notice of compliance and enter the market.

How to Calculate the Deadline

The 45‑day period runs from the date of service, not the date the NOA was drafted or mailed. Under the PM(NOC) Regulations, service is typically personal service or an equivalent method permitted by the Federal Courts Rules. Count calendar days from the day after service. If the 45th day falls on a weekend or federal holiday, the general rule under the Federal Courts Rules is that the deadline extends to the next business day, but practitioners should confirm this calculation with counsel, as missing the deadline by even one day is fatal to the automatic stay.

Decision Matrix: Strategic Factors

When to Consider an Interim Injunction Application

In rare circumstances, for instance, where the second person has already launched at risk or the automatic stay has not attached, the first person may need to seek an interim or interlocutory injunction. The Federal Court applies the well‑known three‑part test: serious issue to be tried, irreparable harm, and balance of convenience. Industry observers note that interim injunctions in the PM(NOC) context are difficult to obtain because the statutory stay mechanism is intended to be the primary protective tool. Nonetheless, where the stay is unavailable (for example, if the 45‑day deadline was missed in respect of one patent but proceedings were commenced on another), an injunction application should be evaluated promptly, ideally within the first two weeks.

Drafting the Section 6 Application: Pleading Traps and Essential Documents

Successfully responding to a notice of allegation in Canada patent form requires more than meeting the deadline, the statement of claim must be carefully drafted to withstand early challenge and align with the Federal Court’s Case and Trial Management Guidelines for PM(NOC) proceedings. Pleading deficiencies can lead to motions to strike, delay, or, critically, loss of the regulatory stay.

Minimum Exhibits to Attach

• Patent Register printout. A dated, certified printout of every Patent Register entry relevant to the NOA, demonstrating the patent was listed at the material time.
• Copy of the NOA and detailed statement. The complete NOA as served, including every page of the second person’s detailed statement of legal and factual basis.
• Certified copy of the patent(s). The Canadian patent(s) at issue, including all claims.
• Claims chart. A chart mapping the relevant patent claims to the second person’s proposed product, identifying each element of the claim and the corresponding feature of the generic product.
• Claim construction brief. A preliminary position on how the patent claims should be construed, referencing the patent specification and prosecution history.
• Form IV filing confirmation. Evidence that the patent was properly listed on the Patent Register using the prescribed form.
• Expert evidence plan. A summary identifying the technical and scientific experts the first person intends to rely on, with their fields of expertise and proposed scope of testimony.

How to Frame Relief

The statement of claim should seek a declaration that the making, constructing, using, or selling of the second person’s drug in the form, dosage, and strength contemplated by the ANDS would infringe the patent. Under the current PM(NOC) framework, the court’s determination on this point is what prevents or permits Health Canada from issuing the notice of compliance. Additional relief typically requested includes a declaration of patent validity (in response to invalidity allegations in the NOA), costs, and any further relief the court considers just. Where a CSP is in play, the claim should address infringement during both the base patent term and the CSP period.

Seven Common Pleading Traps

• Trap 1, Vague infringement particulars. Failing to plead specific claim elements and their correspondence to the second person’s product invites a motion to strike for insufficient particularity.
• Trap 2, Ignoring allegations in the detailed statement. Every factual and legal allegation in the NOA’s detailed statement must be addressed. Uncontested allegations may be taken as admitted.
• Trap 3, Wrong patent or wrong register entry. Naming a patent not listed on the Patent Register at the relevant time, or one not referenced in the NOA, creates a jurisdictional gap the second person will exploit.
• Trap 4, Incorrect party identification. Naming the wrong entity as defendant (for example, listing the parent company instead of the specific ANDS holder) can be fatal if not corrected promptly.
• Trap 5, Failure to address all NOA patents. If the NOA addresses multiple patents and the first person commences proceedings on only some, the stay may not apply to the unaddressed patents, potentially allowing market entry.
• Trap 6, Missing the 45‑day deadline by one day. There is no grace period. Filing on day 46 means no automatic stay, regardless of the merits of the infringement claim.
• Trap 7, Inadequate service of the statement of claim. Even if filed on time, the proceedings are not properly commenced if the statement of claim is not served in accordance with the Federal Courts Rules. Use personal service or an accepted alternative and retain proof.

Sample Filing and Service Timeline

Case Management: Stays, Counterclaims and Urgent Motions

Once the section 6 action is commenced, the PM(NOC) Regulations impose an automatic stay: Health Canada will not issue a notice of compliance to the second person until the earlier of the court’s final determination or the expiry of 24 months from the date the action was commenced. The Federal Court’s Case and Trial Management Guidelines for PM(NOC) proceedings govern how these matters are managed, and compliance with those guidelines is critical.

Defence Options and Counterclaims in a Section 6 Action

The second person will typically counterclaim for a declaration of patent invalidity, relying on grounds such as anticipation, obviousness, insufficiency of disclosure, or overbreadth, often mirroring the allegations set out in the NOA’s detailed statement. The second person may also seek a declaration of non‑infringement. The first person should anticipate these counterclaims during the initial drafting phase and ensure that the statement of claim pre‑emptively addresses validity by including particulars of the patent’s validity and the inventive contribution.

The Federal Court assigns a case management judge to PM(NOC) proceedings early in the life of the action. Industry observers expect that the case management judge will set a compressed schedule, often targeting trial within 18 to 24 months. Key procedural milestones to prepare for include:

• Case management conference. Typically scheduled within weeks of the statement of defence being filed; sets the procedural timetable.
• Document production. Focused and often expedited in PM(NOC) cases; relevance disputes should be flagged early.
• Expert evidence. Fact and expert evidence are usually filed by affidavit or will‑say statement, with cross‑examination to follow.
• Motions. Motions to strike, for summary judgment, or to shorten or extend the 24‑month stay period are common and should be budgeted for.

The second person may also bring a motion to dismiss the action for delay or abuse of process if the first person fails to prosecute the action diligently, reinforcing the importance of meeting every procedural deadline once proceedings are commenced.

Practical Templates and Checklists, What to Prepare in the 45 Days

The following four checklists provide a practical framework for organising the response within the 45‑day window. Each is designed to be adapted to the specific facts of the NOA received.

Checklist 1: NOA Triage (Days 1–3)

• Confirm date and method of service, retain proof (courier receipt, affidavit of service, or email timestamp).
• Log the NOA in the matter management system with a 45‑day countdown alert.
• Identify all patents referenced in the NOA and pull Patent Register entries.
• Determine whether each listed patent is still in force (check expiry dates and any CSP).
• Identify the second person’s product (DIN, dosage form, medicinal ingredient) using the notice of compliance database.
• Issue an internal litigation hold notice covering all documents related to the patents, the drug product and communications with Health Canada.
• Notify insurer or parent‑company stakeholders as required by corporate governance policies.

Checklist 2: Section 6 Application Exhibit Assembly (Days 7–30)

• Certified copy of each patent at issue (with claims pages flagged).
• Dated Patent Register printouts (timestamped screenshots).
• Copy of NOA and detailed statement (complete, unredacted).
• Form IV filing confirmation and any Health Canada correspondence regarding listing.
• Claims chart mapping patent claims to the second person’s proposed product.
• Preliminary claim construction brief.
• Expert CVs and proposed scope of expert evidence.
• Draft statement of claim (for internal review and sign‑off).

Checklist 3: Preservation and Early Discovery Steps (Days 1–14)

• Send litigation hold notices to R&D, regulatory affairs, manufacturing and business development teams.
• Preserve all prosecution history files for each patent.
• Preserve all clinical data, formulation records and correspondence with Health Canada relating to the innovator product.
• Identify and preserve any prior art searches conducted during patent prosecution.
• Preserve any communications with the second person or its agents (e.g., licence negotiations).
• Engage e‑discovery vendor if document volume warrants.

Checklist 4: External Counsel Briefing Memo Template

• Header: matter name; date NOA served; 45‑day deadline date; in‑house contact.
• Section A, NOA summary: patents addressed; nature of each allegation (invalidity, non‑infringement, inapplicability); key factual assertions in detailed statement.
• Section B, Patent Register status: attach printouts; note any discrepancies, late additions or missing listings.
• Section C, Preliminary infringement assessment: in‑house view on claim construction and likely infringement position; flag any prior art concerns.
• Section D, Commercial context: remaining patent term; product revenue; number of pending or anticipated NOAs from other generics; settlement parameters.
• Section E, Decision required: recommend whether to commence section 6 action; identify risks of each option; propose timeline.

Sample Chronology Table

How to Read Health Canada Patent Register Entries

The Health Canada Patent Register is the authoritative database that triggers, and delimits, PM(NOC) rights. Misreading an entry, or failing to detect a late‑added patent, can compromise the entire section 6 action. Below is a field‑by‑field guide to interpreting entries and spotting practical red flags.

• Red flag, late addition. If the “Date Patent Added” is after the second person’s submission filing date, the patent may not trigger NOA obligations. This is a frequent ground for motions to dismiss.
• Red flag, claim type mismatch. If the patent is listed under “use” claims but the NOA only addresses “formulation” claims, there may be listed claims that are not covered by the NOA, creating separate tactical considerations.
• Red flag, CSP granted after NOA served. A Certificate of Supplementary Protection granted after the NOA was served raises questions about whether the CSP period is covered by the existing section 6 proceedings. Counsel should assess whether a supplementary pleading or separate action is required.

Always pull entries on at least two separate dates (the day of receipt and the day before filing the statement of claim) to demonstrate that the register status has not changed. Retain the full URL, the date stamp from the website header, and a PDF printout or screenshot of the complete entry.

Federal Court Practice Points and Recent Procedural Updates

The Federal Court has published Practice Directions and Case and Trial Management Guidelines specifically addressing proceedings under the PM(NOC) Regulations. These guidelines set expectations for compressed timelines, proportionality in discovery, and the court’s active case management role. Key practice points include:

• E‑filing. All documents must be filed electronically through the Federal Court’s e‑filing portal. Confirm formatting requirements before the filing deadline, non‑compliant filings may be rejected.
• Case management conferences. The court expects parties to attend the first case management conference with a proposed schedule that contemplates trial within the 24‑month statutory window.
• Proportionality. Document requests and examinations for discovery are expected to be proportionate to the issues in dispute. Overly broad discovery requests will be curtailed.
• Bifurcation. In some cases the court may bifurcate validity and infringement issues. Practitioners should consider whether to request bifurcation at the first case management conference.

Practitioners should review the Federal Court’s notices page regularly for updates, as practice directions are amended periodically to reflect evolving judicial expectations and procedural efficiencies.

Responding to a Notice of Allegation in Canada Patent Form, Conclusion and Recommended Next Steps

The 45‑day window to respond to a notice of allegation in Canada patent form is unforgiving. Missing it eliminates the automatic regulatory stay and exposes the innovator to unprotected generic entry. To maximise your position:

1. Treat the date of service as day zero, calculate and diarise the 45‑day deadline immediately.
2. Complete all Patent Register and Form IV verification within the first seven days.
3. Make the commence‑or‑negotiate decision no later than day 21, leaving adequate time to draft and file.
4. Assemble all exhibits, including the claims chart, Patent Register printouts and expert evidence plan, before day 35.
5. File and serve the statement of claim no later than day 43 to build in a safety margin.

Organisations that invest in pre‑built NOA response protocols, triage checklists, pre‑vetted counsel relationships and standing expert arrangements, consistently perform better in section 6 proceedings. For teams facing their first NOA or seeking to benchmark their processes, engaging experienced IP litigation counsel early in the 45‑day window remains the single most effective step. Additional context on protecting intellectual property across borders may also be valuable for innovators with multi‑jurisdictional patent portfolios.

Sources

1. Health Canada, Guidance Document: Patented Medicines (Notice of Compliance) Regulations
2. Patented Medicines (Notice of Compliance) Regulations (SOR/93‑133), Justice Laws
3. Patent Act (R.S.C., 1985, c. P‑4), Justice Laws
4. Health Canada, Patent Register
5. Federal Court of Canada, Notices and Practice Directions
6. Canada Gazette, Regulatory Amendment Record (PM(NOC) Amendments)